Researchers are excited about the medication , a novel dual compound showing significant outcomes in early trials for weight reduction . It acts by targeting both pathways : GLP-1 and GIP, which , when https://zaynmcwo600750.onesmablog.com/a-new-possibility-for-weight-management-82118457